Cargando…
Gene Editing Technologies to Target HBV cccDNA
Hepatitis B virus (HBV) remains a significant cause of mortality and morbidity worldwide, since chronic HBV infection is associated with elevated risk of cirrhosis and hepatocellular carcinoma. Current licensed therapies against HBV efficiently suppress viral replication; however, they do not have s...
Autores principales: | Martinez, Maria Guadalupe, Smekalova, Elena, Combe, Emmanuel, Gregoire, Francine, Zoulim, Fabien, Testoni, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787400/ https://www.ncbi.nlm.nih.gov/pubmed/36560658 http://dx.doi.org/10.3390/v14122654 |
Ejemplares similares
-
Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs
por: Li, Feng, et al.
Publicado: (2016) -
The Role of cccDNA in HBV Maintenance
por: Allweiss, Lena, et al.
Publicado: (2017) -
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
por: Allweiss, Lena, et al.
Publicado: (2023) -
HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
por: Liu, Shousheng, et al.
Publicado: (2019) -
Mapping the Interactions of HBV cccDNA with Host Factors
por: Mohd-Ismail, Nur K., et al.
Publicado: (2019)